Microbot Medical Gets FDA Clearance for LIBERTY® Robot
Accelerated Launch Readiness Plans Position Company for Commercialization throughout This autumn 2025 The Company’s Initial Addressable Market Includes Approximately 2.5 Million Peripheral Endovascular Procedures within the U.S. Annually CEO, President & Chairman to Present Live Webcast on the H.C. Wainwright Annual Investor Conference on September 9, 2025, at 9 AM ET. Microbot Medical Inc. (Nasdaq: MBOT),…
